VERICI DX PLC

Regulatory News Service • Nov 6, 2025

National Storage Mechanism | Additional information

RNS Number : 3944G

Verici Dx PLC

06 November 2025

Verici Dx plc

("Verici Dx" or the "Company")

Provider Participation Agreement with Prime Health Services

Verici Dx Plc, (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces that it has signed a Provider Participation Agreement ('the Agreement') with Prime Health Services ('Prime Health'), a dynamic healthcare technology US based company focused on delivering innovative, data-driven solutions through its Preferred Provider Organization ('PPO') network.

PPO networks were established to bring predictability and consistency to pricing in healthcare. They negotiate on behalf of insurance companies to gain discounted pricing, which benefits healthcare companies by bringing a uniform price in reimbursement within the PPO network and fewer denials from the insurance reimbursement. It also provides Physicians with greater confidence in ordering as there is more certainty in the cost to their patients which in turn provides greater cost transparency to the patient. The insurance plans also benefit from having the PPO networks successfully negotiate this contracted price from both a cost efficiency perspective as well as competitive appeal.

Prime Health is one of the fastest-growing preferred provider networks in the US and has more than 850,000 providers across the 50 states, processing around 35 million claims per year. Prime Health's PPO network serves a wide array of clients, including insurance carriers, third-party administrators, self-insured organisations, government entities, and captive insurance groups which provides significant opportunity for Verici Dx to expand its patient scope.

Patti Connolly, Chief Operating Officer at Verici Dx, said: "This agreement with Prime Health is an important milestone for Verici Dx, as we accelerate our commercial reach, expanding our patient network and supporting our approach to increased coverage from private payors. We look forward to updating shareholders on additional agreements of this nature in due course."

Verici Dx plc	www.vericidx.com
Sara Barrington, CEO	Via Walbrook PR
Singer Capital Markets (Nominated adviser, Joint Broker)		Tel: +44 (0)20 7496 3000
Phil Davies / Sam Butcher
Oberon Capital (Joint Broker)	Tel: +44 (0)20 3179 0500
Mike Seabrook
Walbrook PR (Media & Investor Relations)	Tel: +44 (0)20 7933 8780 or [email protected]
Alice Woodings / Paul McManus	Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

AGRFSEESIEISELF